When can stereotactic core biopsy replace excisional biopsy?--A clinical perspective

Area of Science:

• Radiology and Oncologic Imaging
• Breast Pathology
• Minimally Invasive Procedures

Background:

• Stereotactic core biopsy is a minimally invasive alternative to surgical biopsy for mammographic abnormalities.
• It aims to provide histologic diagnosis, reduce patient trauma, and lower healthcare costs.
• Accurate characterization of lesions is crucial for effective breast cancer treatment planning.

Purpose of the Study:

• To review the diagnostic accuracy of stereotactic core biopsy for ductal carcinoma in situ and invasive breast cancer.
• To assess the capability of core biopsy in characterizing malignant breast lesions for treatment planning.
• To examine the cost-effectiveness of core biopsy in managing mammographic abnormalities.

Main Methods:

• Systematic review of published literature on stereotactic core biopsy.
• Evaluation of studies reporting diagnostic accuracy and lesion characterization.
• Analysis of cost-effectiveness data in relation to mammographic suspicion and treatment.

Main Results:

• Core biopsy demonstrates high diagnostic accuracy for ductal carcinoma in situ and invasive breast cancer.
• The technique is effective in characterizing malignant lesions, guiding treatment decisions.
• Cost-effectiveness is supported, particularly for suspicious mammographic findings, when compared to surgical biopsy.

Conclusions:

• Stereotactic core biopsy is a reliable and cost-effective method for diagnosing and characterizing breast cancer.
• It significantly reduces the need for more invasive surgical procedures.
• This technique facilitates appropriate treatment planning, improving patient outcomes and resource utilization.